About the MFM Global Registry
The Cardiatis Multilayer Flow Modulator is a disruptive technology. It is an innovative Stent which represents a new concept in the management of Aortic disease. The mode of action of this device is completely different from that of conventional aortic devices, which has caused much scepticism among the vascular community worldwide. However, positive clinical outcomes have forced a more thorough investigation of this new device and the team at the Western Vascular Institute have been commissioned to undertake this exploratory task.
The Western Vascular Institute is heading an independent registry to collect data from the surgeons and interventionalists around the world who have used this stent to treat thoracoabdominal aortic pathologies. The experienced team at the Western Vascular Institute will objectively analyse the clinical outcomes in patients treated with this stent as well as engaging in independent biomedical testing of the device.
What We've Achieved
- Presented at national/international vascular conferences
- Won awards for our research
- Published in national/international vascular journals